Fisher & Paykel Healthcare is lowering the proportion of sales it makes in United States dollars by up to 2 percentage points a year through the establishment of new markets, chief executive Mike Daniell says.
The East Tamaki-based medical device manufacturer has been increasing sales in the local currencies of countries such as Turkey, Canada, Hong Kong and Japan, which lessens its exposure to volatility in the kiwi-greenback exchange rate.
The New Zealand dollar, which hit a post-float record of US87.43c against the greenback in August, has made business challenging for many local exporters.
Fisher & Paykel Healthcare's interim result, released yesterday, showed operating revenue in US dollars grew 18 per cent to US$205.7 million in the six months to September 30, compared with the same period last year.
Converted into New Zealand dollars, however, operating revenue grew just 3 per cent to $252 million, which despite the exchange rate pressure was a record.